Kidney Week

Abstract: FR-PO1076

Bringing Hemodialysis Home: Outcomes of Qatar's Assisted Home Hemodialysis (HD) Program

Session Information

• Home Dialysis: Modalities, Barriers, Utilization, and Clinical Outcomes
  October 23, 2026 | Location: Exhibit Hall A, Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

• 802 Dialysis: Home Dialysis and Peritoneal Dialysis

Authors

• Abdelhameed, Moayad Hamadelneil Ali, Hamad Medical Corporation, Doha, Qatar

Moayad Hamadelneil Ali Abdelhameed, MBBS

• Yasin, Fadumo Yusuf, Hamad Medical Corporation, Doha, Qatar

Fadumo Yusuf Yasin, RN

• Ibrahem, Mahmoud Suliman Mohammed Salih, Hamad Medical Corporation, Doha, Qatar

Mahmoud Suliman Mohammed Salih Ibrahem, MD, MBBS

• Mohamed, Mohamed, Hamad Medical Corporation, Doha, Qatar

Mohamed Mohamed, MD

• Elshirbeny, Mostafa, Hamad Medical Corporation, Doha, Qatar

Mostafa Elshirbeny, MD

• Al-Ali, Fadwa S., Hamad Medical Corporation, Doha, Qatar

Fadwa S. Al-Ali, MD

• Filali, Mossab, Hamad Medical Corporation, Doha, Qatar

Mossab Filali, MD

• Chembolu, Sandhya, Hamad Medical Corporation, Doha, Qatar

Sandhya Chembolu, RN

• Hamad, Abdullah Ibrahim, Hamad Medical Corporation, Doha, Qatar

Abdullah Ibrahim Hamad, MD, FASN

• Al-Malki, Hassan A., Hamad Medical Corporation, Doha, Qatar

Hassan A. Al-Malki, MD

Background

In Qatar, the number of elderly HD patients is increasing, and many are experiencing limited mobility, this led Qatar to establish an assisted home hemodialysis (AHHD) program to address major transportation and care burdens. Trained nurses deliver hemodialysis in patients' houses. This study evaluates the development of the program, clinical quality indicators, and patient satisfaction and outcomes.

Methods

A retrospective cohort study was performed for all hemodialysis patients transitioned to AHHD in the period July 2021-December 2025. Data were collected from the national electronic medical record, and satisfaction was evaluated using standardized routine surveys.

Results

A total of 211 patients were enrolled in the AHHD program. Of these, 141 patients are still active, 35 died and the rest discontinued due to return to in-center hemodialysis, travel abroad and/or kidney transplantation (Figure 1). Mean age: 70 ± 12 years, 52% female. 1.6 years was the median duration for AHHD. High comorbidity burden included 91% hypertension and 79% diabetes mellitus. Patient's performance in clinical quality indicators was noted: 92% of patients obtained dialysis adequacy with Kt/V greater than 1.2, 65% of the patient achieved the hemoglobin target (ranging from 10 to 12 g/dL), and at least 60% of the patient obtained the parathyroid hormone level in the target range (150 to 500 pg/mL). Vascular access distribution, 27 percent had an arteriovenous fistula, 73 percent dialyzed via a tunneled dialysis catheter. Patient and family satisfaction was extremely high at 98.9%.

Conclusion

Despite serving a frail, elderly and highly comorbid ESKD population, the AHHD program in Qatar showed rapid and notable growth, high patient and family satisfaction, and favorable clinical quality measures. By reducing transportation burdens and providing home-based dialysis via trained nursing assistance, this model provides a patient-centered and scalable approach for patients in need of maintenance hemodialysis.

Acknowledgment

I would like to acknowledge my supervisor and all the team members who contributed to this project.